When change is not an end, but a new management of balance
Menopause is not a disease, but a profound physiological transition. Yet, for many women, this phase manifests as a series of subtractions: less energy, reduced tissue elasticity, and a different perception of their physical well-being.
At the root of these changes lies a precise biological fact: the drastic reduction in estradiol production. This deficiency does not only affect mood or hot flashes, but silently alters the health of the genitourinary system, leading to what is defined as vaginal atrophy.
Hormonal efficiency as a factor of quality of life
The female human body is regulated by a constant dialogue between the pituitary gland and ovaries. With menopause, this dialogue becomes a loud monologue: the follicle-stimulating hormone (FSH) increases in an attempt to stimulate ovaries that no longer respond, while estrogen levels decline.
This deficiency is directly reflected in the Vaginal Maturity Index (VMI). When VMI decreases, tissues lose vascularization and hydration. This is where scientific research seeks safe alternatives to hormone replacement therapy (HRT), exploring the potential of plant-based phytoestrogens.
Why Nigella sativa has become the subject of clinical research
Nigella sativa (known as black cumin) is a plant rich in thymoquinone, flavonoids, and phenolic compounds. These molecules act as phytoestrogens: they are able to bind to estrogen receptors and partially mimic their biological activity.
While in the past its efficacy had mainly been observed in animal models, a recent randomized clinical trial has finally tested Nigella sativa seed extract directly in post-menopausal women.
Estradiol: a return to stability
The research results indicate that supplementation with Nigella sativa extract (at dosages of 910 mg and 1365 mg per day) produces a significant increase in serum estradiol levels after eight weeks.
- In the placebo group: estradiol levels remained unchanged or slightly decreased.
- In the intervention groups: a marked increase was observed, suggesting that the plant may effectively support the hormonal profile without altering FSH levels.
Vaginal health: beyond the symptom
One of the most relevant aspects of the study concerns the improvement of the Vaginal Maturity Index (VMI). A VMI value above 52 is considered an indicator of tissue health, while lower values indicate atrophy.
Treatment with Nigella sativa led the average VMI of participants above the critical threshold of 52 points, unlike the placebo group which remained in a condition of atrophy. This means more elastic tissues, better lubricated and less prone to inflammation or trauma.
A matter of dosage and safety
The study showed that there are no significant differences between taking 910 mg and 1365 mg: both dosages provide comparable benefits. For this reason, the research suggests that the minimum effective dose (910 mg/day) is the most rational choice.
The safety profile proved to be solid, with rare cases of nausea leading to treatment discontinuation, confirming Nigella sativa as a promising natural strategy to support women during this phase of life.
Aging with awareness, not inertia
Supporting the body during menopause does not mean trying to stop time, but providing cells with the tools to function efficiently even in a hormonally altered context. Nigella sativa is not a shortcut, but a bioactive support that, when integrated into a healthy lifestyle, helps reduce the physiological cost of the menopausal transition.
If your company is interested in creating or manufacturing a product for the management of menopause symptoms:
Source: Sukatendel K et al., “Effect of Nigella sativa seed extract on estradiol, FSH levels, and vaginal maturity index in menopausal women: A randomized controlled trial”, Narra J, 2025, https://doi.org/10.52225/narra.v5i1.1399
